Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A downloadable resource for educators, health & research professionals to help develop young peoples’ understanding of AMR and positive actions they can take to mitigate it.

Child showing coronaviruses drawn on her hand, with pills, and a red cross drawn on a adult hand © Stutika Thapa Shrestha YAAR! Youth working group Nepal

Working in partnership with young people in Kenya, Vietnam, Thailand and Nepal, a team from the Oxford Tropical Network have developed a learning resource to support educators, health professionals and researchers as they work with children and youth to better understand AMR.

Download 'An Antimicrobial Resistance Learning Framework for Children and Young People' on the Zenodo website

Solutions to the emerging challenge of antimicrobial resistance (AMR) will require ideas and actions from a wide range of people including children and young people.  In order for them to meaningfully engage with the challenge and contribute to solutions, they need a clear understanding of AMR, its causes, effects and current strategies for mitigation.  This learning framework is a resource for teachers, educators, research scientists and informal learning providers to enable them to develop young peoples’ understanding of:

  • The science behind AMR
  • The individual, community and global health risks AMR presents
  • The positive actions they can take to mitigate against AMR

The framework identifies key learning outcomes appropriate to different age groups that are applicable across a diverse range of settings and learning environments. It can be used as a tool for structuring curricula and learning activities.

This framework was developed by the Youth Against Antimicrobial Resistance (YAAR!) team who includes researchers, engagement practioners, young people and teachers. The team was led by Dr Mary Chambers in Vietnam, Mr Vu Duy Thanh, Prof Phaik Yeong Cheah in Thailand, Prof Sam Kinyanjui in Kenya, Dr Alun Davis in Oxford and Prof Abhilasha Karkey in Nepal.  The project was commissioned by Wellcome Education team in partnership with the Drug Resistant Infections team. 

Visit the YAAR! website for more information

Similar stories

Patient recruitment on track in Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa

Today is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.

TACT-CV study shows artemether–lumefantrine plus amodiaquine an effective treatment for multidrug-resistant malaria in GMS

A triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.

Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes

A new malaria study using a very large analysis of pooled individual patient data (IPD) from more than 70,000 patients of all ages, has been published in BMC Medicine by the WorldWide Antimalarial Resistance Network Falciparum Haematology Study Group

Study finds steady increase in WHO-validated artemisinin resistance markers in Asia

From 2002-2018, there has been a steady increase in the places and proportion of infected people reporting validated kelch13 (K13) artemisinin resistance markers, according to a study in The Lancet Microbe. This increase in artemisinin resistance threatens efforts to eliminate malaria in Asia by 2030 — and control efforts in other endemic regions. The authors say that more consistent data collection, over longer time periods in the same areas, and rapid sharing of data are needed to map the spread of resistance and better inform policy decisions.

Global Research on AntiMicrobial resistance (GRAM) project

Antimicrobial resistance (AMR) is responsible for at least 1.27 million deaths per year — with over 97,000 deaths in 2019 in SE Asia alone, according to a study published in The Lancet by the Global Research on AntiMicrobial resistance (GRAM) project, who urged urgent action from policymakers and health communities to avoid further preventable deaths.

Susie, Phaik Yeong, Richard and Paul among new full Oxford professors!

In the 2021 Oxford Recognition of Distinction round, four MORU colleagues were awarded Full Professor title.